MedTrace Logo

Colorectal Liver Metastases: Novel Assessment Tools for Technical Resectability

NCT04270851 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2020-02-17

No results posted yet for this study

Summary

The CoNoR study aims to assess whether the use of the LiMAx test and the HepaT1ca pre-operative planning magnetic resonance scan impact upon technical resectability decision-making in colorectal liver metastases (CLM).

Conditions

Interventions

DIAGNOSTIC_TEST

LiMAx test

The LiMAx test is a fully licenced liver function test, testing liver maximum capacity via a breath test.

DIAGNOSTIC_TEST

HepaT1ca magnetic resonance scan

The HepaT1ca scan is a pre-operative magnetic resonance scan providing a detailed report permitting interactive virtual pre-operative planning prior to liver surgery.

Sponsors & Collaborators

  • Manchester University NHS Foundation Trust

    collaborator OTHER_GOV

  • Perspectum

    collaborator INDUSTRY

  • The Christie NHS Foundation Trust

    collaborator OTHER

  • The Royal College of Surgeons of England

    collaborator OTHER

  • University of Manchester

    lead OTHER

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-30
Primary Completion
2021-03-31
Completion
2021-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04270851 on ClinicalTrials.gov